29 reports of this reaction
9.7% of all ACETAMINOPHEN AND IBUPROFEN reports
#2 most reported adverse reaction
DRUG EFFECTIVE FOR UNAPPROVED INDICATION is the #2 most commonly reported adverse reaction for ACETAMINOPHEN AND IBUPROFEN, manufactured by AFT Pharmaceuticals US, Inc.. There are 29 FDA adverse event reports linking ACETAMINOPHEN AND IBUPROFEN to DRUG EFFECTIVE FOR UNAPPROVED INDICATION. This represents approximately 9.7% of all 299 adverse event reports for this drug.
Patients taking ACETAMINOPHEN AND IBUPROFEN who experience drug effective for unapproved indication should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG EFFECTIVE FOR UNAPPROVED INDICATION is moderately reported among ACETAMINOPHEN AND IBUPROFEN users, representing a notable but not dominant share of adverse events.
In addition to drug effective for unapproved indication, the following adverse reactions have been reported for ACETAMINOPHEN AND IBUPROFEN:
The following drugs have also been linked to drug effective for unapproved indication in FDA adverse event reports:
DRUG EFFECTIVE FOR UNAPPROVED INDICATION has been reported as an adverse event in 29 FDA reports for ACETAMINOPHEN AND IBUPROFEN. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG EFFECTIVE FOR UNAPPROVED INDICATION accounts for approximately 9.7% of all adverse event reports for ACETAMINOPHEN AND IBUPROFEN, making it one of the most commonly reported side effect.
If you experience drug effective for unapproved indication while taking ACETAMINOPHEN AND IBUPROFEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.